AmREIT, Inc. Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2014-09-30..
- Stock-based compensation / revenue · 12 months: Value 1.89%; Formula and calculation Share-based compensation / revenue. Period ending 2014-09-30..
- Interest coverage · 12 months: Value 1.40×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2014-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2014-09-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.89% | Share-based compensation / revenue. Period ending 2014-09-30. $983.00K ÷ $52.02M × 100 ≈ 1.89% |
| Interest coverage · 12 months | 1.40× | Operating income ÷ reported interest expense. $14.12M ÷ $10.09M ≈ 1.40× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 52.02M USD | |
| Stock-based compensation | 983.00K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 14.12M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 10.09M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | (m) | $52.02M | $983.00K | $14.12M | $10.09M | (m) | 1.89% | 1.40× | Reported |
| 2014-06-30 | (m) | $49.87M | $983.00K | $13.43M | $9.79M | (m) | 1.97% | 1.37× | Reported |
| 2014-03-31 | (m) | $48.06M | $947.00K | $12.89M | $9.58M | (m) | 1.97% | 1.35× | Reported |
| 2013-12-31 | (m) | $47.20M | $948.00K | $12.69M | $9.60M | (m) | 2.01% | 1.32× | Reported |
| 2013-09-30 | (m) | $45.56M | $948.00K | $11.51M | $9.35M | (m) | 2.08% | 1.23× | Reported |
| 2013-06-30 | (m) | $43.81M | $5.46M | $12.21M | $9.78M | (m) | 12.45% | 1.25× | Reported |
| 2013-03-31 | (m) | $42.94M | $5.31M | $13.19M | $10.11M | (m) | 12.36% | 1.30× | Reported |
| 2012-12-31 | (m) | $41.12M | $5.30M | $13.88M | $10.25M | (m) | 12.89% | 1.35× | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $36.72M | $762.00K | $14.01M | $9.97M | (m) | 2.08% | 1.41× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $33.37M | $1.67M | $7.05M | $9.54M | (m) | 5.00% | 0.74× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $35.02M | $580.00K | $10.88M | $9.15M | (m) | 1.66% | 1.19× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.